TWi Pharmaceuticals

1 2

/ Press Releases: 2016.09; TWi Confirms Patent Challenge Relating to Its Paragraph IV ANDA Filing for a Generic Equivalent to Androgel 1.62%; 2015.09; TWi Pharmaceuticals Issues GDR and raised NT$ 2.83 Billion; 2015.09; TWi Pharmaceuticals President & CEO Ms. Tina Guilder will resign from her current roles and Chairman Dr. Chih-Ming Chen will become interim President & CEO; 2015.08; TWi Pharmaceuticals Announces 2Q 2015 Financial Results and EPS for 2Q of NT$0.69; 2015.08; TWi Biotechnology Receives Notice of Patent Allowance for Its Lead Drug Candidate AC-201 for the Indication of Type II Diabetes in Europe and Russia